14-day Premium Trial Subscription Try For FreeTry Free
NASDAQ:ITEK
Delisted

Inotek Pharmaceuticals Corporation Fund Predictions

$3.04
+0 (+0%)
At Close: Jan 22, 2018
Currently predicting for Wed, 24 Apr 2024

Trading levels for ITEK

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 3.04 0.00000000 %
R2 3.04 0.00000000 %
R1 3.04 0.00000000 %
Current price: 3.04
Support S1 3.04 0.00000000 %
S2 3.04 0.00000000 %
S3 3.04 0.00000000 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 0 .
R2 0 .
R1 3.20 5.26 %
Current price 3.04
Support S1 2.61 -14.14%
S2 2.48 -18.42%
S3 2.47 -18.75%

ITEK Predictions History

6 years ago
Venkat.Dhanaraj.12530 predicted that ITEK for 2017-10-04 is going $1.33 (-34.80%)

Rank:

7 years ago
PeteKTF predicted that ITEK for 2017-02-06 is going $1.60 (-5.88%)

7 years ago
PeteKTF predicted that ITEK for 2017-02-01 is going $1.55 (-3.13%)

7 years ago
JS predicted that ITEK for 2017-01-06 is going $1.70 (3.03%)

Click to get the best stock tips daily for free!

About Inotek Pharmaceuticals Corporation

Inotek Pharmaceuticals Corporation, a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of therapies for glaucoma and other diseases of the eye in the United States. The company’s lead product candidate includes Trabodenoson, a monotherapy that is in Phase III clinical trials for lowering IOP by restoring the eye’s natural pressure control mechanism. It is also developing Trabodenoson plus La... ITEK Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT